These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1615728)

  • 1. [Anti-arrhythmic drug prevention of sudden cardiac death--the status after the CAST study].
    Seipel L; Kühlkamp V
    Z Gesamte Inn Med; 1992 May; 47(5):189-94. PubMed ID: 1615728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
    Zrenner B; Koller B; Rudolph W
    Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ventricular tachyarrhythmia. Drug therapy and evaluation of success].
    Seipel L; Kühlkamp V
    Z Kardiol; 1993; 82 Suppl 5():155-61. PubMed ID: 8154157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].
    Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R
    Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sudden cardiac death--possibilities and limits of drug therapy].
    Manz M; Lüderitz B
    Z Kardiol; 1992 May; 81(5):237-45. PubMed ID: 1621403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiarrhythmic agents: current situation].
    Bonhorst D
    Rev Port Cardiol; 1995 May; 14(5):421-9, 362. PubMed ID: 7654403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Can sudden death be prevented by drugs?].
    Amann FW
    Schweiz Rundsch Med Prax; 1990 Sep; 79(39):1142-8. PubMed ID: 1699258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [What is the latest in anti-arrhythmia therapy?].
    Gloor HO
    Schweiz Med Wochenschr; 1991 Nov; 121(47):1711-4. PubMed ID: 1720259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary prevention of myocardial infarct with anti-arrhythmia drugs and beta receptor blockaders].
    Mösslacher H
    Wien Med Wochenschr; 1984 Dec; 134(23-24):566-72. PubMed ID: 6152091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden cardiac death--an approach to management of the patient at risk.
    Podrid PJ; Blatt CM
    Herz; 1984 Apr; 9(2):65-76. PubMed ID: 6714916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of experimental and clinical methods on the effectiveness and side effect profile of anti-arrhythmia agents].
    Kuck KH
    Z Kardiol; 1992; 81 Suppl 4():151-5. PubMed ID: 1283932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term antiarrhythmic pharmaco-therapy guided by Holter monitoring in patients with malignant ventricular arrhythmias and ischemic heart disease.
    Trusz-Gluza M; Gasior Z; Wnuk-Wojnar AM; Filipecki A; Szydło K; Giec L
    Mater Med Pol; 1992; 24(4):229-32. PubMed ID: 1308049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification of patients with complex ventricular arrhythmias. Value of ambulatory electrocardiographic recording, programmed electrical stimulation and the signal-averaged electrocardiogram.
    el-Sherif N; Turitto G; Fontaine JM
    Herz; 1988 Jun; 13(3):204-14. PubMed ID: 2456972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
    Arós Borau F; Loma-Osorio A; Torres Bosco A
    Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical use of beta-blockers in the prevention of sudden death.
    Coumel P; Leclercq JF; Zimmerman M
    Eur Heart J; 1986 May; 7 Suppl A():187-201. PubMed ID: 2873039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac insufficiency: prevention of ventricular arrhythmias].
    Mabo P; Leclercq C; Pavin D
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():23-8. PubMed ID: 10830085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiarrhythmic agents in the prevention of sudden cardiac death].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):117-20. PubMed ID: 10365592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.